With More Than 250,000 Alzheimer’s Patients, VA Is a Market for New Drug
Now that the Food and Drug Administration has granted Fast Track approval for the new Alzheimer’s disease medication Leqembi, the issue of who will pay for it looms large.
Now that the Food and Drug Administration has granted Fast Track approval for the new Alzheimer’s disease medication Leqembi, the issue of who will pay for it looms large.
In the early days and months of the COVID-19 pandemic, the VA and other healthcare systems were focused on the daunting work of helping patients survive the acute effects of the disease.
With the PACT Act set to officially go into effect this month, legislators are watching VA closely to see how the department deals with the hundreds of thousands of expected new claims.
While the pandemic has resulted in an explosion in the use of telehealth among federal health agencies, it also has created opportunities for fraud and waste, according to a recent joint report from six Offices of the Inspector General (OIGs).
While it is well understood that prostate cancer (PCa) and its treatment can have significant and pervasive sexual side effects for the male patients, less attention has been paid to their partners.